Titolo |
Pubblicato in |
Anno |
Loss of ATP2C1 function promotes trafficking and degradation of NOTCH1: Implications for Hailey-Hailey disease |
EXPERIMENTAL DERMATOLOGY |
2023 |
5FU/Oxaliplatin-induced Jagged1 cleavage counteracts apoptosis induction in colorectal cancer: a novel mechanism of intrinsic drug resistance |
FRONTIERS IN ONCOLOGY |
2022 |
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL |
CANCERS |
2022 |
When viruses cross developmental pathways |
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY |
2021 |
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy |
CANCERS |
2021 |
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response |
ONCOGENESIS |
2020 |
A dynamic role of mastermind-like 1: a journey through the main (path)ways between development and cancer |
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY |
2020 |
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer |
CANCERS |
2019 |
Notch3 targeting. A novel weapon against ovarian cancer stem cells |
STEM CELLS INTERNATIONAL |
2019 |
Histone Modifications Drive Aberrant Notch3 Expression/Activity and Growth in T-ALL |
FRONTIERS IN ONCOLOGY |
2019 |
Notch/CXCR4 partnership in acute lymphoblastic leukemia progression |
JOURNAL OF IMMUNOLOGY RESEARCH |
2019 |
Notch signaling activation as a hallmark for triple-negative breast cancer subtype |
JOURNAL OF ONCOLOGY |
2019 |
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP |
NATURE COMMUNICATIONS |
2019 |
Wnt, notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer |
FRONTIERS IN GENETICS |
2019 |
Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains CRC progression and chemoresistance |
CANCER RESEARCH |
2019 |
PLK1 targets NOTCH1 during DNA damage and mitotic progression |
THE JOURNAL OF BIOLOGICAL CHEMISTRY |
2019 |
Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response |
The Biennial Congress of the Italian Association of cell biology and differentiation |
2019 |
Notch/{CXCR}4 Partnership in Acute Lymphoblastic Leukemia Progression |
JOURNAL OF IMMUNOLOGY RESEARCH |
2019 |
Notch signaling as a therapeutic target for acute lymphoblastic leukemia |
EXPERT OPINION ON THERAPEUTIC TARGETS |
2018 |
NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. |
Atti del ABCD - PPh.D. meeting |
2018 |